Novartis targets Turkey for plant, other expansion; Piramal gets grant for ADC plant in Scotland;

> Novartis ($NVS) director Alexandre F. Jetzer Chung reportedly said that company is planning a new manufacturing plant in Turkey and sees that country as potentially replacing Egypt as the center of healthcare for North Africa. Item

> A £145,000 grant from Scottish Enterprise was given to Piramal Healthcare to entice the Indian company to open manufacturing operations in Grangemouth, Scotland, where it will make antibody-drug conjugates (ADC). Story

> The Medicines and Healthcare Products Regulatory Agency has posted a warning for U.K. surgeons to stop using a specific combination of metal hip products from Stryker Corp. ($SYK) and Johnson & Johnson ($J&J) because of the "unacceptably high" failure rates. Article

> Cleveland-based Research Organics has been acquired by Sigma Aldrich to expand its capacity of buffer production and increase its pharmaceutical-grade raw material lines. Story

> Gerresheimer Medical Plastic Systems has added a pharmaceutical packaging assembly area with 3 clean rooms to its facility in Regensburg Germany. News

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.